Prevalence of alcohol use disorders in schizophrenia - A systematic review and meta-analysis

Acta Psychiatrica Scandinavica

Volumn 120, Issue 2, 2009, Pages 85-96

  Koskinen, J ^a   Lohonen J ^a   Koponen, H ^b,c   Isohanni, M ^a   Miettunen, J ^a  

^a UNIVERSITY OF OULU   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c ACADEMY OF FINLAND   (Finland)

Author keywords

Alcohol; Schizophrenia; Substance use disorders

Indexed keywords

ALCOHOL DERIVATIVE;

ALCOHOL ABUSE; ALCOHOLISM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE DURATION; EUROPE; GROUPS BY AGE; HUMAN; LIFESPAN; NORTH AMERICA; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEX DIFFERENCE; SYSTEMATIC REVIEW;

ALCOHOL-RELATED DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; PREVALENCE; SCHIZOPHRENIA;

EID: 67649979716     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01385.x     Document Type: Review

References (81)

1. Mueser KT, Yarnold PR, Levinson DF et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 1990 16 : 31 55.
2. Cantor-Graae E, Nordström LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 2001 48 : 69 82. (Pubitemid 32241184)
3. Potvin S, Sepehry AA, Stip E. A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychol Med 2006 36 : 431 440. (Pubitemid 43380996)
4. Potvin S, Sepehry A, Stip E. Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia. Aust N Z J Psychiatry 2007 41 : 792 799. (Pubitemid 47399957)
5. Drake RE, Mueser KT. Alcohol-use disorder and severe mental illness. Alcohol Health Res World 1996 20 : 87 93. (Pubitemid 126698328)
6. Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res 1999 35 (suppl. 93 100.
7. Gregg L, Barrowclough C, Haddock G. Reasons for increased substance use in psychosis. Clin Psychol Rev 2007 27 : 494 510. (Pubitemid 46431229)
8. Sterne JAC, Bradburn MJ, Egger D. Meta-analysis in stata. In : Egger M, Davey Smith G, Altman D, eds. Systematic reviews in health care: meta-analysis in context. London : BMJ Publishing Group, 2001.
9. Stata Corporation. stata User's Guide. College Station, TX : Stata Press, 2001.
10. Addington J, Addington D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatr Scand 2007 115 : 304 309. (Pubitemid 46425747)
11. Akvardar Y, Tumuklu M, Akdede BB, Ulas H, Kitis A, Alptekin K. Substance use among patients with schizophrenia in a university hospital. Bull Clin Psychopharmacol 2004 14 : 191 197. (Pubitemid 40093265)
12. Altamura AC, Bassetti R, Bignotti S, Pioli R, Mundo E. Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study. Schizophr Res 2003 1 : 47 55. (Pubitemid 36015787)
13. Archie S, Rush BR, Akhtar-Danesh N et al. Substance use and abuse in first-episode psychosis: prevalence before and after early intervention. Schizophr Bull 2007 33 : 1354 1363. (Pubitemid 350022769)
14. Barnett JH, Werners U, Secher SM et al. Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry 2007 190 : 515 520. (Pubitemid 46868836)
15. Bühler B, Hambrecht M, Löffler W, An der Heiden W, Häfner H. Precipitation and determination of the onset and course of schizophrenia by substance abuse -a retrospective and prospective study of 232 population-based first illness episodes. Schizophr Res 2002 54 : 243 251. (Pubitemid 34304217)
16. Clark R, Haiyi X, Brunette M. Bezodiazepine Prescription Practices and Substance Abuse in Persons With Severe Mental Illness. J Clin Psychiatry 2004 65 : 151 155.
17. Compton MT, Furman AC, Kaslow NJ. Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: preliminary evidence from an African American first-episode sample. Schizophr Res 2004 71 : 61 64. (Pubitemid 39209476)
18. Compton MT, Weiss PS, West JC, Kaslow NJ. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems. Soc Psychiatry Psychiatr Epidemiol 2005 40 : 939 946. (Pubitemid 43115894)
19. Compton MT, Esterberg ML, Druss BG, Walker EF, Kaslow NJ. A descriptive study of pathways to care among hospitalized urban African American first-episode schizophrenia-spectrum patients. Soc Psychiatry Psychiatr Epidemiol 2006 41 : 566 573. (Pubitemid 44404438)
20. Dawe S, Seinen A, Kavanagh D. An Examination of the Utility of the AUDIT in People with Schizophrenia. J Stud Alcohol 2000 61 : 744 750.
21. De Lisi L, Mesen A, Rodriguez C et al. Clinical characteristics of schizophrenia in multiply affected Spanish origin families from Costa Rica. Psychiatr Genet 2001 11 : 145 152. (Pubitemid 32980614)
22. Depp CA, Davis CE, Mittal D, Patterson TL, Jeste DV. Health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder. J Clin Psychiatry 2006 67 : 215 221. (Pubitemid 43357467)
23. Dervaux A, Bayle FJ, Laqueille X et al. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia? Am J Psychiatry 2001 158 : 492 494. (Pubitemid 32205213)
24. Dervaux A, Bayle FJ, Laqueille X et al. Validity of the CAGE questionnaire in schizophrenic patients with alcohol abuse and dependence. Schizophr Res 2006 81 : 151 155. (Pubitemid 43107689)
25. Deshmukh A, Rosenbloom MJ, Pfefferbaum A, Sullivan EV. Clinical signs of cerebellar dysfunction in schizophrenia, alcoholism, and their comorbidity. Schizophr Res 2002 57 : 281 291. (Pubitemid 35240031)
26. Di Michele V, Bolino F. The Natural Course of Schizophrenia and Psychopathological Predictors of Outcome. Psychopathology 2004 37 : 98 104.
27. Dubertret C, Bidard I, Ades J, Gorwood P. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction. Schizophr Res 2006 86 : 284 290. (Pubitemid 44234044)
28. Farrelly S, Harris MG, Henry LP et al. Prevalence and correlates of comorbidity 8 years after a first psychotic episode. Acta Psychiatr Scand 2007 116 : 62 70. (Pubitemid 46889771)
29. Fischer EP, Owen RR, Cuffel BJ. Substance abuse, community service use, and symptom severity of urban and rural residents with schizophrenia. Psychiatr Serv 1996 47 : 980 984. (Pubitemid 26303422)
30. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998 24 : 443 455. (Pubitemid 28378229)
31. Gråwe RW, Pedersen PB, Widen JH. Changes in prevalence and comorbidity in a total population of patients with psychotic disorders in Norwegian psychiatric hospitals. Nord J Psychiatry 1997 51 : 127 132. (Pubitemid 27223071)
32. Gut-Fayand A, Dervaux A, Olie JP, Lôo H, Poirier MF, Krebs MO. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res 2001 102 : 65 72. (Pubitemid 32463926)
33. Harkavy-Friedman J, Restifo K, Malaspina D et al. Suicidal behavior in schizophrenia: Characteristics of individuals who had and had not attempted suicide. Am J Psychiatry 1999 156 : 1276 1278. (Pubitemid 29374893)
34. Harkavy-Friedman J, Kimhy D, Nlson E, Venarde DF, Malaspina D, Mann JJ. Suicide attempts in schizophrenia: The role of command auditory hallucinations for suicide. J Clin Psychiatry 2003 64 : 871 874. (Pubitemid 37022751)
35. Haro JM, Novick D, Suarez D, Alonso J, Lépine JP, Ratcliffe M. SOHO study group remission and relapse in the outpatient care of schizophrenia: Three-year results from the Schizophrenia Outpatient Health Outcomes study. J Clin Psychopharmacol 2006 26 : 571 578. (Pubitemid 44772733)
36. Holthausen EA, Wiersma D, Sitskoorn MM et al. Schizophrenic patients without neuropsychological deficits: subgroup, disease severity or cognitive compensation? Psychiatry Res 2002 15 : 1 11.
37. Kamali M, Kelly L, Gervin M, Browne S, Larkin C, O'Callaghan E. The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia. Acta Psychiatr Scand 2000 101 : 452 456. (Pubitemid 30365567)
38. Kamali M, Kelly BD, Clarke M et al. A prospective evaluation of adherence to medication in first episode schizophrenia. Eur Psychiatry 2006 21 : 29 33. (Pubitemid 43243050)
39. Karam EG, Yabroudi PF, Melhem NM. Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: a study from Lebanon. Compr Psychiatry 2002 43 : 463 468. (Pubitemid 35375523)
40. Kavanagh DJ, Waghorn G, Jenner L et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr Res 2004 66 : 115 124. (Pubitemid 38041109)
41. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch Gen Psychiatry 1996 53 : 1022 1031. (Pubitemid 26384671)
42. Kirkpatrick B, Amador XF, Flaum M et al. The deficit syndrome in the DMS-IV Field Trial: I. Alcohol and other drug abuse. Schizophr Res 1996 20 : 69 77. (Pubitemid 26387505)
43. Krausz M, Haasen C, Mass R, Wagner HB, Peter H, Freyberger HJ. Harmful use of psychotropic substances by schizophrenics: coincidence, patterns of use and motivation. Eur Addict Res 1996 2 : 11 16. (Pubitemid 26071089)
44. Kuo CJ, Tsai SY, Lo CH, Wang YP, Chen CC. Risk factors for completed suicide in schizophrenia. J Clin Psychiatry 2005 66 : 579 585.
45. Leslie D, Rosenhech MD. Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system. Med Care 2001 39 : 923 933.
46. Lin CH, Chen CC, Wang SY, Lin SC, Chen MC, Lin CH. Factors affecting time to rehospitalization in Han Chinese patients with schizophrenic disorder in Taiwan. Kaohsiung J Med Sci 2008 24 : 408 413.
47. Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr Res 2004 67 : 157 166. (Pubitemid 38251445)
48. McCreadie RG, Scottish Comorbidity Study Group. Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. Br J Psychiatry 2002 181 : 321 325. (Pubitemid 35178564)
49. McGirr A, Tousignant M, Routhier D et al. Risk factors for completed suicide in schizophrenia and other chronic psychotic disorders:a case-control study. Schizophr Res 2006 84 : 132 143.
50. Messias E, Bienvenu J. Suspiciousness and alcohol use disorders in schizophrenia. J Nerv Ment Dis 2003 191 : 387 390. (Pubitemid 36782119)
51. Modestin J, Gladen C, Christen S. A Comparative Study on Schizophrenic Patients with Dual Diagnosis. J Addict Dis 2001 29 : 41 51. (Pubitemid 33095748)
52. Moilanen K, Veijola J, Läksy KM et al. Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort. Soc Psychiatry Psychiatr Epidemiol 2003 38 : 305 310. (Pubitemid 37160799)
53. Mueser KT, Yarnold PR, Rosenberg SD, Swett C, Miles KM, Hill D. Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophr Bull 2000 26 : 179 192. (Pubitemid 30317704)
54. Nesvåg R, Frigessi A, Jönsson EG, Agartz I. Effects of alcohol consumption and antipsychotic medication on brain morphology in schizophrenia. Schizophr Res 2007 90 : 52 61. (Pubitemid 46177572)
55. Olfson M, Mechanic D, Boyer C, Hansell S, Walkup J, Weiden PJ. Assessing clinical predictions of early rehospitalization in schizophrenia. J Nerv Ment Dis 1999 187 : 721 729. (Pubitemid 30036718)
56. Pristach CA, Smith CM. Self-reported effects of alcohol use on symptoms of schizophrenia. Psychiatr Serv 1996 47 : 421 423. (Pubitemid 26109297)
57. Rabinowitz J, Mark M, Popper M, Slyuzberg M. Reported comorbidity of mental disorders with substance abuse among psychiatric inpatients in Israel. J Ment Health Adm 1996 23 : 471 478.
58. Rabinowitz J, Bromet EJ, Lavelle J, Carlson G, Kovasznay B, Schwartz JE. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychol Med 1998 28 : 1411 1419. (Pubitemid 28521606)
59. Ringen PA, Melle I, Birkenaes AB et al. The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illness. Acta Psychiatr Scand 2008 118 : 297 304.
60. Rossi Menezes P, Ratto LR. Prevalence of substance misuse among individuals with severe mental illness in São Paulo. Soc Psychiatry Psychiatr Epidemiol 2004 39 : 212 217. (Pubitemid 39369131)
61. Sim K, Swapna V, Mythily S et al. Psychiatric comorbidity in first episode psychosis: the Early Psychosis Intervention Program (EPIP) experience. Acta Psychiatr Scand 2004 109 : 23 29. (Pubitemid 38161097)
62. Soliman A, Reza H. Risk factors and correlates of violence among acutely ill adult psychiatric inpatients. Psychiatr Serv 2001 52 : 75 80. (Pubitemid 32039809)
63. Verdoux H, Liraud F, Gonzales B, Assens F, Abalan F, van Os J. Predictors and outcome characteristics associated with suicidal behaviour in early psychosis: a two-year follow-up of first-admitted subjects. Acta Psychiatr Scand 2001 103 : 347 354. (Pubitemid 32436747)
64. Wade D, Harrigan S, Harris MG, Edwards J, McGorry PD. Pattern and correlates of inpatient admission during the initial acute phase of first-episode psychosis. Aust N Z J Psychiatry 2006 40 : 429 436.
65. Wilk JE, West JC, Narrow WE et al. Comorbidity patterns in routine psychiatric practice: is there evidence of underdetection and underdiagnosis? Compr Psychiatry 2006 47 : 258 264. (Pubitemid 43849681)
66. Wobrock T, Sittinger H, Behrendt B, D'Amelio R, Falkai P, Caspari D. Comorbid substance abuse and neurocognitive function in recent- onsetschizophrenia. Eur Arch Psychiatry Clin Neurosci 2007 257 : 203 210. (Pubitemid 47036718)
67. Xafenias A, Diakogiannis I, Iacovides A, Fokas K, Kaprinis G. Factors affecting hospital length of stay: Is substance use disorder one of them? A study in a Greek public psychiatric hospital Am J Addict 2008 17 : 447 451.
68. Ziedonis M, Trudeau K. Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schizophr Bull 1997 23 : 229 238. (Pubitemid 27224875)
69. Frances RJ. Schizophrenia and substance abuse. Psychiatr Ann 1996 26 : 523 527. (Pubitemid 126631348)
70. Buckley P. Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness. J Clin Psychiatry 2006 67 (suppl. 5 9. (Pubitemid 44378993)
71. Shaw J, Hunt IM, Flynn S et al. The role of alcohol and drugs in homicides in England and Wales. Addiction 2006 101 : 1117 1124. (Pubitemid 44025311)
72. Kanato M. Drug use and health among prison inmates. Curr Opin Psychiatry 2008 21 : 252 254.
73. Kaczynski Pollock N, Martin CS, Langenbucher JW. Diagnostic concordance of DSM-III, DSM-III-R, DSM-IV and ICD-10 alcohol diagnoses in adolescents. J Stud Alcohol 2000 61 : 439 446. (Pubitemid 30246957)
74. Hiller W. Alcohol dependence in ICD-9 and DSM-III-R: a comparative polydiagnostic study. Eur Arch Psychiatry Neurol Sci 1989 239 : 101 108. (Pubitemid 19240525)
75. Cottler LB. Comparing DSM-III-R and ICD-10 substance use disorders. Addiction 1993 88 : 689 696.
76. Grant BF, Harford TC, Hasin DS, Chou P, Pickering R. DSM-III-R and the proposed DSM-IV alcohol use disorders, United States 1988: A nosological comparison. Alcohol Clin Exp Res 1992 16 : 215 221.
77. Schuckit MA, Hesselbrock V, Tipp J, Anthenelli R, Bucholz K, Radziminski S. A comparison of DSM-III-R, DSM-IV and ICD-10 substance use disorders diagnoses in 1922 men and women subjects in the COGA study. Addiction 1994 89 : 1629 1638.
78. Grant BF. ICD-10 and proposed DSM-IV harmful use of alcohol/alcohol abuse and dependence, United States 1988: Nosological comparison. Alcsm Clin Exp Res 1993 17 : 1093 1101. (Pubitemid 24000532)
79. WHO. Global Status Report on Alcohol. Geneva: Switzerland : Department of Mental Health and Substance Abuse, World Health Organization, 2004.
80. Kraemer HC, Wilson KA, Hayward C. Lifetime prevalence and pseudocomorbidity in psychiatric research. Arch Gen Psychiatry 2006 63 : 604 608. (Pubitemid 43848291)
81. Stroup D, Berlin J, Morton S et al. Meta-analysis of observational studies in epidemiology. A proposal for reporting. JAMA 2000 283 : 2008 2012. (Pubitemid 30214957)